Inhibitors of nuclear factor kappa B cause apoptosis in cultured macrophages

Mediators of Inflammation

Volumn 6, Issue 3, 1997, Pages 225-232

  Mannick, E E ^a   Mishra, J ^a   Marque, J ^a   Clavell, M ^a   Miller, M J S ^a   Oliver, P D ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Macrophage; Nuclear factor B

Indexed keywords

CALPASTATIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; PHORBOL 13 ACETATE 12 MYRISTATE; PYRROLIDINE DERIVATIVE; PYRROLIDINE DITHIOCARBAMIC ACID; TOSYLLYSYL CHLOROMETHYL KETONE; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL SURVIVAL; CONTROLLED STUDY; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA; MURINAE;

EID: 0030755371     PISSN: 09629351     EISSN: None     Source Type: Journal    
DOI: 10.1080/09629359791721     Document Type: Article

References (53)

1. Baeuerle P, Henkel T. Function and activation of NF-κB in the immune system. Annu Rev Immunol 1995; 12: 141-179.
2. Sharma HW, Narayanan R. The NK-κB transcription factor in oncogenesis. Anticancer Res 1996; 16: 589-596.
3. Higgins KA, Perez JR, Coleman TA, et al. Antisense inhibition of the p65 subunit of NF-κB blocks tumorigenicity and causes tumor regression. Proc Natl Acad Sci USA 1993; 90: 9901-9905.
4. Franzoso G, Bours V, Park S, Tomita-Yamaguchi M, Kelly K, Siebenlist U. The candidate oncoprotein Bcl-3 is an antagonist of p50/NF-κB-mediated inhibition. Nature 1992; 359: 339-342.
5. Ivanov VN, Deng G, Podack ER, Malek TR. Pleiotropic effects of Bcl-2 on transcription factors in T cells: potential role of NF-κB p50-p50 for the anti-apoptotic function of Bcl-2. Int Immunol 1995; 7: 1709-1720.
6. Slater AF, Kimland M, Jiang SA, Orrenius S. Constitutive nuclear NF-κB/ rel DNA-binding activity of rat thymocytes is increased by stimuli that promote apoptosis, but not inhibited by pyrrolidine dithiocarbamate. Biochem J 1995; 312: 833-838.
7. Kuwakado K, Kubata M, Bessho R, et al. Augementation by aphidicolin of 1-beta-D-arbino-furanosylcytosine-induced c-jun and NF-κB activation in a human myeloid leukemia cell line: correlation with apoptosis. Leuk Res 1995; 19: 645-650.
8. Tong L, Perez-Polo JR. Transcription factor DNA binding activity in PC12 cells undergoing apoptosis after glucose deprivation. Neurosci Lett 1995; 191: 137-140.
9. Bessho K, Matsubara K, Kubata M et al. Pyrrolidine dithiocarbamate, a potent inhibitor of nuclear factor kappa B (NF-κB) activation, prevents apoptosis in human promyelocyte leukemia HL-60 cells and thymocytes. Biochem Pharmacol 1994; 48: 1883-1889.
10. Lin KI, Lee SH, Narayanan R, Baraban JM, Hardwick JM, Ratan RR. Thiol agents and Bcl-2 identify an alphavirus-induced apoptotic pathway that requires activation of the transcription factor, NF-κB. J Cell Biol 1995; 131: 1149-1161.
11. Higuchi M, Singh S, Chan H, Aggarwal BB. Protease inhibitors differentially regulate tumor necrosis factor-induced apoptosis, nuclear factor κB activation, cytotoxicity, and differentiation. Blood 1995; 86: 2248-2256.
12. Park A, Baichwal VR. Systematic mutational analysis of the death domain of the tumor necrosis factor receptor 1-associated protein, TRADD. J Biol Chem 1996; 271: 9858-9862.
13. Hsu H, Shu HB, Pan MG, Goeddel DV. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 1996; 84: 299-308.
14. Hsu H, Huang J, Shu HB, Baechual V, Goeddel DV. TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity 1996; 4: 387-396.
15. Tsai JC, Jain M, Hsieh CM, et al. Induction of apoptosis by pyrrolidine dithiocarbamate and N-acetyl cysteine in vascular smooth muscle cells. J Biol Chem 1996; 271: 3667-3670.
16. McCabe MJ, Orrenius S. Genistein induces apoptosis in immature thymocytes by inhibiting topoisomerase-II. Biochem Biophys Res Commun 1993; 194: 944-950.
17. Trede NS, Castigli E, Geha RS, Chatila T. Microbiol superantigens induce NF-κB in the human monocytic cell line, THP-1. J Immunol 1993: 150: 5604-5613.
18. Scheinman RI, Cogswell PC, Lofquist AK, Baldwin AS Jr. Role of transcriptional activation of I κB alpha in mediation of immunosuppression by glucocorticoids. Science 1995; 270: 283-286.
19. Wyllie AH. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 1980; 284: 555-556.
20. Bertrand R, Solary E, O'Conner P, Kohn KW, Pommier Y. Induction of a common pathway of apoptosis by staurosporine. Exp Cell Res 1994; 211: 314-321.
21. Ishikawa Y, Mukaida N, Kuno K, Rice N, Okamoto SI, Matsushima K. Establishment of lipopolysaccharide-dependent nuclear factor κB activation in a cell-free system. J Biol Chem 1995; 270: 4158-4164.
22. Beg AA, Sha WC, Bronson RT, Ghosh S, Baltimore D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature 1995; 376: 167-170.
23. Sarma V, Lin Z, Clark L, et al. Activation of the B-cell receptor. CD40, induces A20, a novel zinc finger protein that inhibits apoptosis. J Biol Chem 1995; 270: 12343-12346.
24. Beg AA, Baltimore D. An essential role for NF-κB in preventing TNF-α-induced cell death. Science 1996; 274: 782-784.
25. Wang CY, Mayo MW, Baldwin AS Jr. TNF- and cancer therapy-induced apoptosis: potentiation by inhihition of NF-κB. Science 1996; 274: 784-787.
26. Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM. Suppression of TNF-α-induced apoptosis by NF-κB. Science 1996; 274: 787-789.
27. Wu M, Arsura M, Bellas RE, et al. Inhibitors of c-myc expression induces apopotosis of WEHI 231 murine B cells. Mol Cell Biol 1996; 16: 5015-5125.
28. Grilli M, Pizzi M, Memo M, Spano P. Neuroprotection by aspirin and sodium salicylate through blockade of NF-κB activation. Science 1996; 274: 1383-1385.
29. Barnes PJ, Karin M. Mechanisms of disease: Nuclear factor-κB. A pivotal transcription factor in chronic inflammatory diseases. New Engl J Med 1997; 326: 1066-1071.
30. Kruppa G, Thoma B, Machleidt T, Wiegmann K, Kronke M. Inhibition of tumor necrosis factor (TNF)-mediated NF-κB activation by selective blockade of the human 55-kDa TNF receptor. J Immunol 1992; 148: 3152-3157.
31. Sgone R, Boeck G, Dietrich H, Gruber J, Richeis H, Wick G. Simultaneous determination of cell surface antigens and apoptosis. Trends Genet 1994; 10: 41-42.
32. Martin SJ. Apoptosis: suicide, execution or murder? Trends Cell Biol 1993; 3: 141-144.
33. Martin DP, Schmidt RE, DiStefano PS, Lowry OH, Carter JG, Johnson EM. Inhibitors of protein synthesis and RNA synthesis prevent neuronal death caused by nerve growth factor deprivation. J Cell Biol 1988; 106: 824-844.
34. Fearnhead HO, Rivett AJ, Dinsdale D, Cohen GM. A pre-existing protease is a common effector of thymocyte apoptosis mediated by diverse stimuli. FEBS Lett 1995; 357: 242-246.
35. Sluvkin II, Jerrells TR. Different pathways of in vitro ethanol-induced apoptosis in thymocytes and splenic T and B lymphocytes. Immunopharmacology 1995; 31: 43-57.
36. Shinohara K, Tomioka M, Nakano H, Tone S, Ho H, Kawashima S. Apoptosis induction resulting from proteasome inhibition. Biochem J 1996; 317(2): 385-388.
37. Zhu W, Murtha PE, Young CY. Calpain inhibitor-induced apoptosis in human prostate adenocarcinoma cells. Biochem Biophys Res Commun 1995; 214: 1130-1137.
38. Henkel T, Machleidt T, Alkalay I, Kronke M, Ben-Neriah Y, Baeuerle PA. Rapid proteolysis of IκB-α is necessary for activation of transcription factor. NF-αB. Nature 1993; 365: 182-185.
39. Lin YC, Brown K, Siebenlist U. Activation of NF-κB requires proteolysis of the inhibitor IκB-α: signal-induced phosphorylation of IκB-α alone does not release active NF-κB. Proc Natl Acad Sci USA 1995; 92: 552-556.
40. Liu ZQ, Kunimatsu M, Yang JP, Ozaki Y, Sasaki M, Okamoto T. Proteolytic processing of nuclear factor κB by calpain in vitro. FEBS Lett 1996; 385: 109-113.
41. Chen Z, Halger J, Palombella VJ et al. Signal-induced site-specific phosphorylation targets I κB alpha to the ubiquitin-proteasome pathway. Genes Dev 1995; 9: 1586-1597.
42. Friedman H, Snyder M. Mutations in PRGI, a yeast proteasome-related gene, cause defects in nuclear division and are suppressed by deletion of a mitotic cyclin gene. Proc Natl Acad Sci USA 1994; 91: 2031-2035.
43. Maki CG, Huibregtse JM, Howley PM. In vivo ubiquitination and proteasome mediated degradation of p53(1). Cancer Res 1996; 56: 2649-2654.
44. Lee HW, Smith L, Petit GR, Vinitsky A, Smith JB. Ubiquitination of protein kinase C-alpha and degradation by the proteasome. J Biol Chem 1996; 271: 20973-20976.
45. Yoshida A, Takauji R, Inuzuka M, Ueda T, Nakamura T. Role of serine and ICE-like proteases in induction of apoptosis by etoposide in human leukemia HL-60 cells. Leukemia Res 1996; 10: 821-824.
46. Mashima T, Naito M, Fujita N, Noguchi K, Tsuruo T. Identification of actin as a substrate of ICE and an ICE-like protease and involvement of an ICE-like protease but not ICE in VP-16-induced U937 apoptosis. Biochem Biophys Res Commun 1995; 217: 1185-1192.
47. Mampuru LJ, Chen SJ, Kalenik JL, Bradley ME, Lee TC. Analysis of events associated with serum deprivation-induced apoptosis in C3H/ So18 muscle satellite cells. Exp Cell Res 1996; 226: 372-780.
48. Estaquier J, Tanaka M, Suda T, Nagata S, Golstein P, Ameisen JC. Fas-mediated apoptosis of CD4+ and CD8+ T cells from human immunodeficiency virus-infected persons: differential in vitro preventive effect of cytokines and protease antagonists. Blood 1996; 87: 4959-4966.
49. Squier MK, Miller AC, Malkinson AM, Cohen JJ. Calpain activation in apoptosis. J Cell Physiol 1994; 159: 229-237.
50. 2 and antioxidants have opposite effects on activation of NF-κB and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J 1993; 12: 20005-20015.
51. Schreck R, Meier B, Mannel DN, Droge W, Baeuerle PA. Dithiocarbamates as potent inhibitors of nuclear factor κB activation in intact cells. J Exp Med 1992; 175: 1181-1194.
52. Imbert V, Rupert RA, Livolsi A, et al. Tyrosine phosphorylation of IκB-α activates NF-κB without proteolytic degradation of IκB-α. Cell 1996; 86: 787-798.
53. Sato M, Brenner I. Oxygen free radicals and metallothionein. Free Rad Biol Med 1993; 14: 325-337.